title: Strongly suspicious hemolysis caused by azacitidine in a myelodysplastic syndrome patient.
authors.affiliation: Division of Hematology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan; Division of Hematology, Department of Internal Medicine, Juntendo University Shizuoka Hospital, Shizuoka, Japan.
authors.forename: Kunimoto
authors.initials: K
authors.lastname: Ichikawa
authors.forename: Nanae
authors.initials: N
authors.lastname: Aritaka
authors.forename: Kanako
authors.initials: K
authors.lastname: Ogura
authors.forename: Norio
authors.initials: N
authors.lastname: Komatsu
authors.forename: Takao
authors.initials: T
authors.lastname: Hirano
mesh_terms: D000368:Aged; D000743:Anemia, Hemolytic / Q000097:blood / Q000139:chemically induced*; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use; D001374:Azacitidine / Q000009:adverse effects* / Q000627:therapeutic use; D006242:Haptoglobins / Q000378:metabolism; D006461:Hemolysis / Q000187:drug effects*; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D012156:Reticulocytes / Q000473:pathology
chemical_list: D000964:Antimetabolites, Antineoplastic; D006242:Haptoglobins; D001374:Azacitidine